Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: dose proportionality and influence of renal impairment
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.